| Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia Commonwealth University … A Abbate, BW Van Tassell, G Biondi-Zoccai, MC Kontos, JD Grizzard, ... The American journal of cardiology 111 (10), 1394-1400, 2013 | 395 | 2013 |
| Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study) BW Van Tassell, R Arena, G Biondi-Zoccai, JMN Canada, C Oddi, ... The American journal of cardiology 113 (2), 321-327, 2014 | 241 | 2014 |
| Interleukin-1 blockade in recently decompensated systolic heart failure: results from REDHART (Recently Decompensated Heart Failure Anakinra Response Trial) BW Van Tassell, J Canada, S Carbone, C Trankle, L Buckley, ... Circulation: Heart Failure 10 (11), e004373, 2017 | 186 | 2017 |
| Interleukin‐1 blockade inhibits the acute inflammatory response in patients with ST‐segment–elevation myocardial infarction A Abbate, CR Trankle, LF Buckley, MJ Lipinski, D Appleton, D Kadariya, ... Journal of the American Heart Association 9 (5), e014941, 2020 | 180 | 2020 |
| Comparative safety of interleukin-1 blockade with anakinra in patients with ST-segment elevation acute myocardial infarction (from the VCU-ART and VCU-ART2 pilot studies) A Abbate, MC Kontos, NA Abouzaki, RD Melchior, C Thomas, ... The American journal of cardiology 115 (3), 288-292, 2015 | 165 | 2015 |
| IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction: Results From DHART2 BW Van Tassell, CR Trankle, JM Canada, S Carbone, L Buckley, ... Circulation: Heart Failure 11 (8), e005036, 2018 | 146 | 2018 |
| Interleukin-1 blockade in acute decompensated heart failure: a randomized, double-blinded, placebo-controlled pilot study BW Van Tassell, NA Abouzaki, CO Erdle, S Carbone, CR Trankle, ... Journal of cardiovascular pharmacology 67 (6), 544-551, 2016 | 122 | 2016 |
| Interleukin‐1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D‐HART2) BW Van Tassell, LF Buckley, S Carbone, CR Trankle, JM Canada, ... Clinical cardiology 40 (9), 626-632, 2017 | 116 | 2017 |
| Heart failure with preserved ejection fraction: refocusing on diastole A Abbate, R Arena, N Abouzaki, BW Van Tassell, J Canada, K Shah, ... International journal of cardiology 179, 430-440, 2015 | 114 | 2015 |
| Usefulness of canakinumab to improve exercise capacity in patients with long-term systolic heart failure and elevated C-reactive protein CR Trankle, JM Canada, L Cei, N Abouzaki, C Oddi-Erdle, D Kadariya, ... The American journal of cardiology 122 (8), 1366-1370, 2018 | 56 | 2018 |
| Rationale and design of the Virginia Commonwealth University–Anakinra Remodeling Trial‐3 (VCU‐ART3): A randomized, placebo‐controlled, double‐blinded, multicenter study BW Van Tassell, MJ Lipinski, D Appleton, CS Roberts, MC Kontos, ... Clinical cardiology 41 (8), 1004-1008, 2018 | 50 | 2018 |
| Effects of prolastin C (plasma-derived alpha-1 antitrypsin) on the acute inflammatory response in patients with ST-segment elevation myocardial infarction (from the VCU-alpha 1 … A Abbate, BW Van Tassell, S Christopher, NA Abouzaki, C Sonnino, ... The American journal of cardiology 115 (1), 8-12, 2015 | 49 | 2015 |
| Prognostic indicators for recurrent thrombotic events in HIV-infected patients with acute coronary syndromes: use of registry data from 12 sites in Europe, South Africa and the … F D’Ascenzo, E Cerrato, D Appleton, C Moretti, A Calcagno, N Abouzaki, ... Thrombosis Research 134 (3), 558-564, 2014 | 34 | 2014 |
| Canada J, Shah K, Biondi-Zoccai G, Voelkel NF A Abbate, R Arena, N Abouzaki, BW Van Tassell Heart failure with preserved ejection fraction: refocusing on diastole. Int …, 2015 | 31 | 2015 |
| Inhibiting the inflammatory injury after myocardial ischemia reperfusion with plasma-derived alpha-1 antitrypsin: a post hoc analysis of the VCU-α1RT study NA Abouzaki, S Christopher, C Trankle, BW Van Tassell, S Carbone, ... Journal of cardiovascular pharmacology 71 (6), 375-379, 2018 | 27 | 2018 |
| Resolution of pericardial constriction with Anakinra in a patient with effusive-constrictive pericarditis secondary to rheumatoid arthritis A Schatz, C Trankle, A Yassen, C Chipko, M Rajab, N Abouzaki, A Abbate International Journal of Cardiology 223, 215-216, 2016 | 23 | 2016 |
| Percutaneous coronary intervention and surgical revascularization in HIV Database (PHD) Study Investigators. Prognostic indicators for recurrent thrombotic events in HIV … F D’Ascenzo, E Cerrato, D Appleton, C Moretti, A Calcagno, N Abouzaki, ... Thromb Res 134 (3), 558-64, 2014 | 22 | 2014 |
| Usefulness of C-reactive protein plasma levels to predict exercise intolerance in patients with chronic systolic heart failure JMN Canada, DT Fronk, LF Cei, S Carbone, CO Erdle, NA Abouzaki, ... The American Journal of Cardiology 117 (1), 116-120, 2016 | 17 | 2016 |
| Interleukin-10 in patients with ST-segment elevation myocardial infarction RA Falcao, S Christopher, C Oddi, L Reznikov, JD Grizzard, NA Abouzaki, ... International Journal of Cardiology 172 (1), e6-e8, 2014 | 15 | 2014 |
| Leukocyte activity in patients with ST-segment elevation acute myocardial infarction treated with anakinra C Sonnino, S Christopher, C Oddi, S Toldo, RA Falcao, RD Melchior, ... Molecular Medicine 20, 486-489, 2014 | 15 | 2014 |
